Thanks for logging in.

You can now click/tap WATCH to start the live stream.

Thanks for logging in.

You can now click/tap LISTEN to start the live stream.

Thanks for logging in.

You can now click/tap LATEST NEWS to start the live stream.

LISTEN
on air now
Advertisement
Advertisement
Advertisement

Genetic Signatures: From $4.9m to $28m in annual revenues in just 3 years

Listen to ASX-listed Genetic Signatures CEO Dr John Melki talk to Matt Birney on the Bulls N’ Bears Report about Genetic Signatures’ remarkable hike in revenue from its test kit that can detect infectious diseases – including COVID-19.

BULLS N' BEARS
Advertisement